OTCMKTS:BLUSF

BELLUS Health (BLUSF) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $14.60
▼
$14.67
50-Day Range: $6.46
▼
$14.51
52-Week Range: $0.49
▼
$2.60

Volume: 542,701 shs
Average Volume: 39,610 shs
Market Capitalization: $2.33 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Headlines

About BELLUS Health (OTCMKTS:BLUSF) Stock

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Receive BLUSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

BLUSF Stock News Headlines

May 12, 2023 | msn.com

BELLUS Health: Q1 Earnings Insights

April 19, 2023 | markets.businessinsider.com

Where BELLUS Health Stands With Analysts

June 4, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

April 18, 2023 | msn.com

GSK to Buy Bellus for $2 Billion to Gain Cough Medicine

April 5, 2023 | seekingalpha.com

Bellus Health posts proof-of-concept data for cough candidate

April 5, 2023 | markets.businessinsider.com

BELLUS: Phase 1 Study Establishes Proof Of Concept For Developing ER Formulation Of Camlipixant

April 5, 2023 | markets.businessinsider.com

BELLUS: Phase 1 Study Establishes Proof Of Concept For Developing ER Formulation Of Camlipixant

March 29, 2023 | americanbankingnews.com

BELLUS Health (OTCMKTS:BLUSF) Hits New 12-Month High at $7.54

June 4, 2023 | Legacy Research (Affiliate) (Ad)

From -60% Account to Doubling His Money?

After helping his readers double their money 13 TIMES in the last year alone… There’s ONE person trader Jeff Clark has NOT been able to help! His 23-year-old son, Grant.

November 14, 2022 | benzinga.com

BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights

November 14, 2022 | msn.com

Bellus Health (BLU) Reports Q3 Loss, Misses Revenue Estimates

October 10, 2022 | yahoo.com

BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting

July 18, 2022 | benzinga.com

BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States

March 10, 2022 | gurufocus.com

Power Corp of Canada Buys BELLUS Health Inc, Sells Alibaba Group Holding, New Oriental ...

February 17, 2022 | gurufocus.com

First Light Asset Management, LLC Buys AtriCure Inc, Keros Therapeutics Inc, BELLUS Health Inc, ...

September 13, 2021 | benzinga.com

What's Going On With BELLUS Health's Stock Today?

September 15, 2020 | seekingalpha.com

BELLUS Health Inc (BLU) Investor Presentation - Slideshow

July 9, 2020 | finance.yahoo.com

Trade Alert: The Chairman of the Board Of BELLUS Health Inc. (TSE:BLU), Francesco Bellini, Has Just Spent US$390k Buying 31% More Shares

November 7, 2019 | www.nasdaq.com

Bellus Health Inc (BLUSF) Option Chain

August 15, 2019 | seekingalpha.com

Bellus Health to reverse split shares 1:3.6

June 20, 2019 | seekingalpha.com

BELLUS Health (BLUSF) Presents At Raymond James Life Sciences & MedTech Conference - Slideshow

June 7, 2019 | seekingalpha.com

BELLUS Health (BLUSF) Presents At Jefferies 2019 Healthcare Conference - Slideshow

See More Headlines

BLUSF Company Calendar

Last Earnings: 5/08/2019
Today: 6/04/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: N/A
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:BLUSF
CUSIP: N/A
CIK: N/A
Web: www.bellushealth.com
Phone: 45-0680-4500
Fax: N/A
Employees: 10
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.10)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-7,010,000.00
Net Margins: -49,910.34%
Pretax Margin: N/A
Return on Equity: -48.37%
Return on Assets: -45.25%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 13.87
Quick Ratio: 13.87

Sales & Book Value

Annual Sales: $30,000.00
Price / Sales: 77,596.06
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.25 per share
Price / Book: 58.52

Miscellaneous

Outstanding Shares: 159,117,000
Free Float: N/A
Market Cap: $2.33 billion
Optionable: Not Optionable
Beta: 1.55

Key Executives

Roberto Bellini
President, Chief Executive Officer & Director

François Desjardins
Vice President-Finance

Denis Garceau
Senior Vice President-Drug Development

Tony Matzouranis
Vice President-Business Development

Sébastien Roy
Secretary

Key Competitors

View All Competitors

BLUSF Stock - Frequently Asked Questions

How were BELLUS Health's earnings last quarter?: BELLUS Health Inc (OTCMKTS:BLUSF) announced its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01. The company had revenue of $0.01 million for the quarter. BELLUS Health had a negative net margin of 49,910.34% and a negative trailing twelve-month return on equity of 48.37%.
What is BELLUS Health's stock symbol?: BELLUS Health trades on the OTCMKTS under the ticker symbol "BLUSF."

What is BELLUS Health's stock price today?: One share of BLUSF stock can currently be purchased for approximately $14.63.
How much money does BELLUS Health make?: BELLUS Health (OTCMKTS:BLUSF) has a market capitalization of $2.33 billion and generates $30,000.00 in revenue each year. The company earns $-7,010,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.
How can I contact BELLUS Health?: BELLUS Health's mailing address is 275 ARMAND-FRAPPIER BLVD., LAVAL A8, H7V 4A7. The official website for the company is www.bellushealth.com. The company can be reached via phone at 45-0680-4500 or via email at fdesjardins@bellushealth.com.

This page (OTCMKTS:BLUSF) was last updated on 6/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BELLUS Health (BLUSF) Stock Forecast, Price & News

About BELLUS Health (OTCMKTS:BLUSF) Stock

BLUSF Stock News Headlines

BLUSF Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BLUSF Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info